1. Secukinumab, a novel anti-IL-17A antibody, exhibits low immunogenicity in clinical trials and human in vitro assays. Issue 1 (October 2016) Authors: Kolbinger, Frank; Blauvelt, Andrew; Armstrong, April; Fox, Todd; Huang, Jiaqing; Liang, Eric; Karle, Annette; Spindeldreher, Sebastian; Bruin, Gerard; Reich, Kristian Journal: Journal of dermatological science Issue: Volume 84:Issue 1(2016:Oct.) Page Start: e122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗